SuperworthKiora Pharmaceuticals shares outstanding KPRX
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 6.2M
- On a year earlier
- +54.9%
- more shares
Kiora Pharmaceuticals had 6.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 54.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 4.2M | −1% |
| FY2024 | 4.2M | +406% |
| FY2023 | 832.7K | +430% |
| FY2022 | 157.2K | +348% |
| FY2021 | 35.1K | +169% |
| FY2020 | 13K | +24% |
| FY2019 | 10.5K | +30% |
| FY2018 | 8.1K | +154% |
| FY2017 | 3.2K | +75% |
| FY2016 | 1.8K | +28% |
| FY2015 | 1.4K | +3731% |
| FY2014 | 37 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 6.2M | +55% | |
| Q1 FY26 | 4.2M | −1% | |
| Q4 FY25 | 4.2M | −1% | |
| Q3 FY25 | 4.4M | +3% | |
| Q2 FY25 | 4M | −4% | |
| Q1 FY25 | 4.2M | +8% | |
| Q4 FY24 | 4.2M | +406% | |
| Q3 FY24 | 4.2M | +434% | |
| Q2 FY24 | 4.2M | +1041% | |
| Q1 FY24 | 3.9M | +1780% | |
| Q4 FY23 | 832.7K | +430% | |
| Q3 FY23 | 789.7K | +738% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Kiora Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.